FONR · As filed with the SEC

Fonar income statement, by quarter

The statement as Fonar presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) · USD thousands, except per-share amounts; shares in thousands

USD thousands, except per-share amounts; shares in thousands	Q3 FY26 3 months ended Mar 31, 2026	Q2 FY26 3 months ended Dec 31, 2025	Q1 FY25 3 months ended Sep 30, 2025	Q4 FY25^† 3 months ended Jun 30, 2025	Q3 FY25 3 months ended Mar 31, 2025	Q4 FY24^† 3 months ended Jun 30, 2024
Revenues
Patient fee revenue – net of contractual allowances and discounts	8,085	7,296	7,572	8,895.45^†	8,853	8,304.80^†
Product sales	75	126	316	363.30^†	55	408.73^†
Service and repair fees	2,162	2,195	2,182	2,187.05^†	2,295	1,992.21^†
Service and repair fees – related parties	45	45	45	45^†	45	45.17^†
Management and other fees	13,118	12,897	12,941	12,453.56^†	12,929	12,204.29^†
Management and other fees – related medical practices	2,987	2,988	2,987	3,331.97^†	2,988	2,987.9^†
Total Revenues – Net	26,472	25,547	26,043	27,276.32^†	27,165	25,943.09^†
Cost and Expenses
Cost of Revenue	4,781	5,014	4,929	4,960.94^†	4,901	4,733.58^†
Costs related to product sales	277	215	324	257.03^†	319	494.16^†
Costs related to service and repair fees	1,163	1,212	1,059	1,297.52^†	1,182	1,044.57^†
Costs related to service and repair fees – related parties	7	11	8	169.50^†	58	38.41^†
Costs related to management and other fees	7,431	7,858	7,812	8,065.05^†	6,897	7,531.60^†
Costs related to management and other fees – related medical practices	1,572	1,543	1,464	1,500.28^†	1,714	1,505.73^†
Research and Development Expense	424	455	440	452.09^†	441	438.95^†
Selling, General and Administrative Expense	8,373	6,239	6,813	9,679.16^†	7,991	8,822.73^†
Total Costs and Expenses	24,028	22,547	22,849	26,381.56^†	23,503	24,609.73^†
Income from Operations	2,444	3,000	3,194	894.76^†	3,662	1,333.36^†
Interest expense	(3)	(4)	(1)	(4.61)^†	(7)	(10.00)^†
Interest income – related party	12	12	12	12.92^†	13	12.96^†
Non-Operating Income (Expense)	363	431	474	492.98^†	463	550.44^†
Other income – related party	—	—	—	—	—	(0.14)^†
Non-Operating Income (Expense)	4	3	3	37.20^†	(1)	32.76^†
Income Before Provision for Income Taxes and Noncontrolling Interests	2,820	3,442	3,682	1,433.24^†	4,130	1,919.39^†
Provision for income taxes	(492)	(903)	(1,012)	(88.81)^†	(1,006)	(284.97)^†
Consolidated Net Income	—	2,539	2,670	—	—	—
Net Income – Noncontrolling Interests	—	(483)	—	—	—	—
Net Income – Attributable to FONAR	—	2,056	—	—	—	—
Consolidated Net Income	2,328	—	—	1,344.43^†	3,124	1,634.42^†
Net Income – Noncontrolling Interests	(687)	—	(406)	(615.17)^†	(618)	(804.02)^†
Net Income – Attributable to FONAR	1,641	—	2,264	729.26^†	2,506	830.40^†
Common Stockholders	1,537	1,924	2,120	680.35^†	2,347	778.92^†
Class A Non Voting Preferred Stockholders	78	98	108	36.44^†	119	38.78^†
Common Class C	26	34	36	12.47^†	40	12.7^†
Common Stockholders	0.25	0.31	0.34	—	0.38	—
Common Class C	0.07	0.09	0.10	—	0.11	—
Common Stockholders	0.24	0.31	0.34	—	0.37	—
Common Class C	0.07	0.09	0.10	—	0.11	—
Weighted Average Shares Outstanding	6,865	6,865	6,865	—	6,865	—
Common Stockholders	6,169	6,169	6,169	—	6,168	—
Common Class C	383	383	383	—	383	—
Common Stockholders	6,296	6,296	6,296	—	6,296	—
Common Class C	383	383	383	—	383	—

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.